1. Home
  2. NTRA vs VIK Comparison

NTRA vs VIK Comparison

Compare NTRA & VIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

N/A

Current Price

$315.96

Market Cap

39.1B

Sector

Health Care

ML Signal

N/A

Logo Viking Holdings Ltd Ordinary Shares

VIK

Viking Holdings Ltd Ordinary Shares

N/A

Current Price

$104.19

Market Cap

43.6B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
NTRA
VIK
Founded
2003
1997
Country
United States
Bermuda
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.1B
43.6B
IPO Year
2015
2023

Fundamental Metrics

Financial Performance
Metric
NTRA
VIK
Price
$315.96
$104.19
Analyst Decision
Strong Buy
Buy
Analyst Count
15
14
Target Price
$259.07
$84.14
AVG Volume (30 Days)
1.2M
1.9M
Earning Date
05-07-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
0.65
N/A
EPS
N/A
N/A
Revenue
$210,939,000.00
N/A
Revenue This Year
$18.08
$14.41
Revenue Next Year
$19.65
$14.16
P/E Ratio
N/A
$37.68
Revenue Growth
N/A
N/A
52 Week Low
$152.62
$56.06
52 Week High
$326.03
$110.09

Technical Indicators

Market Signals
Indicator
NTRA
VIK
Relative Strength Index (RSI) 68.92 56.17
Support Level $186.96 $95.95
Resistance Level N/A $105.76
Average True Range (ATR) 11.35 2.97
MACD 4.76 -0.31
Stochastic Oscillator 84.68 48.72

Price Performance

Historical Comparison
NTRA
VIK

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About VIK Viking Holdings Ltd Ordinary Shares

Viking Holdings Ltd is a travel company, with a fleet of 92 small ships, which view as floating hotels. It offers travel experiences on all seven continents in all three categories of the cruise industry river, ocean, and expedition cruising. The Group defines its products based on the type of cruise offering and language of the cruise service. The River segment provides river cruises outside the United States to English-speaking passengers. The Ocean segment offers ocean cruises to English-speaking passengers. Other include operating segments that are not individually reportable, consisting of expedition cruises for English-speaking passengers (Expedition), Mississippi River cruises for English-speaking passengers, and Viking China, which includes cruises for Mandarin.

Share on Social Networks: